Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 9.244\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) CCC(C)(C)n1nnnc1C(c1ccncc1)N1CCC(Cc2ccccc2)CC1
b.) CC(C)OC(=O)c1ccc(NC(=O)c2ccco2)cc1
c.) CC1CC(C)CN(CC(C)(C)NS(=O)(=O)c2ccccc2)C1
Answer: a. CCC(C)(C)n1nnnc1C(c1ccncc1)N1CCC(Cc2ccccc2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)(C)n1nnnc1C(c1ccncc1)N1CCC(Cc2ccccc2)CC1
CCC(C)(C)n1nnnc1C(c1ccncc1)N1CCC(Cc2ccccc2)CC1
4-[(4-benzylpiperidin-1-yl)-[1-(2-methylbutan-2-yl)tetrazol-5-yl]methyl]pyridine